Skip to main content

School Receives T32 Grant for Training Program in Cancer Nanotechnology

July 13, 2015

A federal grant awarded to the University of North Carolina at Chapel Hill will help grow the workforce of scientists and doctors working in cancer nanotechnology through the launch of a new postdoctoral training program. The University has received a $1.8 million, five-year grant from the National Institutes of Health to create a postdoctoral training program within the UNC Eshelman School of Pharmacy’s Center for Nanotechnology in Drug Delivery researchers. The program will be run in collaboration with the Carolina Institute for Nanomedicine, the Carolina Center for Cancer Nanotechnology Excellence and the UNC Lineberger Comprehensive Cancer Center. The award, a … Continued

Shrewsbury Reappointed to USP Compounding Committee

June 25, 2015

Robert Shrewsbury, PhD, has been elected to serve a second five-year term on the Compounding Expert Committee of the United States Pharmacopeial Convention. The USP publishes the U.S. Pharmacopeia and National Formulary, which sets standards for prescription and over-the-counter drugs and other health-care products sold in the United States and in many other countries. Shrewsbury is an associate professor in the Division of Practice Advancement and Clinical Education at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. He has served as an expert on the USP Compounding Committee since 2010. Since he joined … Continued

Eshelman Institute for Innovation Launches

June 2, 2015

The Eshelman Institute for Innovation at the University of North Carolina at Chapel Hill — created by a historic $100 million gift to the UNC Eshelman School of Pharmacy in December — has officially launched. The Eshelman Institute aims to inspire a culture of innovation where imagination and creative solutions accelerate change in education, research and health care. The institute provides a mechanism for faculty, staff, and students to seek funding for bold ideas and also provides opportunities to educate and train students and postdoctoral fellows; foster collaboration, creativity, and innovation; and stimulate commercialization of intellectual property and entrepreneurial development. The institute … Continued

School Wins TBJ Life Sciences Award for Chemo-Cleaning Wipe

May 22, 2015

The UNC Eshelman School of Pharmacy received a 2015 BDO Life Sciences Award from the Triangle Business Journal on May 21 in the category of outstanding research university. The School won for the work of William Zamboni, PharmD, PhD, and Stephen Eckel, PharmD, MHA, in developing wipe kits that detect and remove hazardous residue left on surfaces from the preparation of chemotherapy drugs. Eckel, a leading expert on the issue of chemotherapy contamination in the workplace, says studies have found that people who prepare and administer chemotherapy drugs are at risk of developing complications from exposure to those drugs. Despite … Continued

Kashuba to Play Role in New UNC-GSK Partnership to Accelerate Search for HIV Cure

May 11, 2015

The University of North Carolina at Chapel Hill, a leading global public research university with significant expertise in HIV basic and clinical research, and GSK, a global, research-based pharmaceutical and health-care company with a legacy of success in developing treatments for HIV, today announced the creation of the dedicated HIV Cure center and a jointly owned new company that will focus on discovering a cure for HIV/AIDS. This unique public-private partnership will redefine the traditional way of conducting research and create a new model to seek the breakthroughs needed to tackle an extraordinarily challenging global health issue. The HIV Cure … Continued

UNC Team Uses Cellular Bubbles to Deliver Parkinson’s Meds Directly to Brain

May 4, 2015

Researchers at the University of North Carolina at Chapel Hill have used exosomes — tiny bubbles of protein and fat produced naturally by cells — to bypass the body’s defenses and deliver a potent biopharmaceutical directly to the brain to treat Parkinson’s disease. Elena Batrakova, PhD, and her colleagues at the UNC Eshelman School of Pharmacy’s Center for Nanotechnology in Drug Delivery extracted exosomes from immune cells and successfully loaded them with the enzyme catalase, a potent antioxidant that counters the neuron-killing inflammation responsible for Parkinson’s and other degenerative neurological disorders. Their work was published in the Journal of Controlled … Continued